FemHealth Ventures, a leading women’s health-focused venture capital firm, a top-decile performer across DPI and IRR for Fund I, announced the close of FemHealth Ventures Fund II at $65 million. The oversubscribed raise brings the firm’s assets under management to $100 million across two funds and further solidifies FemHealth Ventures’ position as a category-defining investor in women’s health innovation.

The fund received significant support from existing limited partners alongside new investors aligned with the firm’s mission to transform women’s health while achieving exceptional financial returns. FemHealth Ventures Fund I, launched in 2021, is recognized as a top-decile performer across DPI and IRR according to Carta and Pitchbook databases.

“We are thrilled to announce the successful close of Fund II, more than doubling the size of our inaugural fund,” said Maneesha Ghiya, Managing Partner of FemHealth Ventures. “This raise reflects growing recognition that women’s health innovation offers both substantial societal impact and compelling investment potential. We are grateful for the trust our limited partners continue to place in us.”

FemHealth Ventures is widely recognized for establishing the industry’s three-category framework defining women’s health as conditions that appear only in women, mostly in women, or differently in women. First introduced in 2019 as part of the FemHealth Framework (© 2019 FemHealth Ventures), this model is now widely used across the sector to guide research, strategy, and investment.

“The next generation of transformative women’s health companies will be led by visionary founders, and we are honored to support them,” added Sara Crown Star, Venture Partner at FemHealth Ventures.

Fund II will continue investing across drugs, devices, diagnostics, and digital / AI-enabled technologies that address unmet needs in women’s health. Fund II remains focused on partnering with exceptional founders who are building solutions that materially improve lives.

About FemHealth Ventures

FemHealth Ventures is a women’s health–focused venture capital firm investing in breakthrough innovations that deliver meaningful health advances and strong investor returns. The firm has been featured in Forbes, The Wall Street Journal, Insider, and CNBC and manages $100 million in assets.

For more information, visit www.femhealthventures.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251217420341/en/

“We are thrilled to announce the successful close of Fund II, more than doubling the size of our inaugural fund,”